Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Toxicologic Pathology|August 22, 2012
Development of a Delayed-Type Hypersensitivity (DTH) Model in the Cynomolgus MonkeyCaroline Bouchez, Fréderic Gervais, Renaud Fleurance, et al.Journal of Psychopharmacology (Oxford, England)|June 21, 2017
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's diseaseSimon Loiodice, Portia McGhan, Vitalina Gryshkova, et al.Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Neuroinflammation in Sepsis: Molecular Pathways of Microglia ActivationCarolina Araújo Moraes, Camila Zaverucha-do-Valle, Renaud Fleurance, et al.Toxicology Letters|January 23, 2018
miR-21-5p as a potential biomarker of inflammatory infiltration in the heart upon acute drug-induced cardiac injury in ratsVitalina Gryshkova, Alisha Fleming, Portia McGhan, et al.Avian Pathology : Journal of the W.V.P.A|January 9, 2009
Congenital cataract in 1-day-old French Mulard ducklingsSara Belluco, Sabine Chahory, Maria Vanore, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 15, 2018
Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney InjuryJana Obajdin, Mabel Cotter, Sara Snelling, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|July 8, 2024
Assessing the interplay between off-target promiscuity, cytotoxicity, and tolerability in rodents to improve the safety profile of novel anti-malarial plasmepsin X inhibitorsHelga H J Gerets, Annie Delaunois, Alvaro Cardenas, et al.Toxicologic Pathology|August 11, 2018
Scientific and Regulatory Policy Committee Points to Consider: Histopathologic Evaluation in Safety Assessment Studies for PEGylated Pharmaceutical ProductsArmando R Irizarry Rovira, Bindu M Bennet, Brad Bolon, et al.Molecular Neurobiology|October 24, 2023
Downregulation of Ubiquitin-Specific Protease 15 (USP15) Does Not Provide Therapeutic Benefit in Experimental Mesial Temporal Lobe EpilepsyUte Häussler, João Neres, Catherine Vandenplas, et al.Regulatory Toxicology and Pharmacology : RTP|January 24, 2021
Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.Pageof 2